The microfluidic chip developed by researchers from Rice University in the US measures the concentration of SARS-CoV-2 nucleocapsid (N) protein, a biomarker for COVID-19, in blood serum from a standard finger prick.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3uBWIGy
via IFTTT
0 comments:
Post a Comment